menu
    • menu

    Company profile for Abcam plc

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    As an innovator in reagents and tools, we provide the research and clinical communities with tools and scientific support. We offer highly validated biological binders and assays to address important targets in critical biological pathways. Already a pioneer in data sharing and ecommerce in the life sciences, our ambition is to be the most influential company in life sciences by helping advance global understanding of biology ...
    As an innovator in reagents and tools, we provide the research and clinical communities with tools and scientific support. We offer highly validated biological binders and assays to address important targets in critical biological pathways. Already a pioneer in data sharing and ecommerce in the life sciences, our ambition is to be the most influential company in life sciences by helping advance global understanding of biology and causes of disease, which, in turn, will drive new treatments and improved health. While we’ve evolved over the years to become a leading provider of life science research tools.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Abcam plcunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Discovery Drive, Cambridge Biomedical Campus, Cambridge, CB2 0AX
    Telephone
    Telephone
    +44 (0)1223 696 000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.abcam.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/abcam
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/abcam

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Citeab Unveils Top 100 Cited RUO Antibodies Showcasing Market
    Citeab Unveils Top 100 Cited RUO Antibodies Showcasing Market

    14 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/citeab-reveals-the-top-100-cited-ruo-antibodies-highlighting-antibody-market-leaders-and-emerging-research-trends-302582998.html

    PR NEWSWIRE
    14 Oct 2025
    Share Share
    Danaher completes $5.7 billion acquisition of Abcam
    Danaher completes $5.7 billion acquisition of Abcam

    07 Dec 2023

    // Khushi Mandowara REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/danaher-completes-57-billion-acquisition-abcam-2023-12-06/

    Khushi Mandowara REUTERS
    07 Dec 2023
    Share Share
    Shareholders of Abcam Approve Proposed Acquisition by Danaher
    Shareholders of Abcam Approve Proposed Acquisition by Danaher

    07 Nov 2023

    // PRESS RELEASE

    https://corporate.abcam.com/shareholders-of-abcam-approve-proposed-acquisition-by-danaher/

    PRESS RELEASE
    07 Nov 2023
    Share Share
    Glass Lewis Joins ISS in Recommending Vote “FOR” Danaher’s Proposed Acquisition of Abcam
    Glass Lewis Joins ISS in Recommending Vote “FOR” Danaher’s Proposed Acquisition of Abcam

    23 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231023970771/en

    BUSINESSWIRE
    23 Oct 2023
    Share Share
    Jonathan Milner releases presentation to Abcam plc shareholders
    Jonathan Milner releases presentation to Abcam plc shareholders

    16 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/16/2760820/0/en/Jonathan-Milner-releases-presentation-to-Abcam-plc-shareholders-outlining-reasons-to-reject-Danaher-s-bid-and-strategic-vision-for-the-Company.html

    GLOBENEWSWIRE
    16 Oct 2023
    Share Share
    Abcam lays out details behind $5.7B Danaher acquisition
    Abcam lays out details behind $5.7B Danaher acquisition

    06 Oct 2023

    // Katherine Lewin ENDPTS

    https://endpts.com/abcam-details-negotiations-behind-5-7b-danaher-acquisition-takeover-attempts-by-founder-and-former-ceo/

    Katherine Lewin ENDPTS
    06 Oct 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search